Best Healthcare Companies in Geneva, Switzerland
The 50 best Healthcare companies in Geneva, Switzerland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Genkyotex.
Ranked: Best Healthcare companies in Geneva
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Genkyotex Small molecule therapeutics that selectively inhibit NOX enzymes | $52M | 95 mo ago | Acquired | — | 2006 | — | 151 patents Small-molecule NADPH oxidase inhibitor drugs for treating oxidative stress diseases | — |
| 2 | Keri Medical Develops and manufactures a range of medical devices for hand and wrist surgery | $43M | 40 mo ago | Acquired | — | 2017 | WordPressMySQLPHP+35 | 16 patents Patents concentrated in health & consumer products | 1 launch |
| 3 | Medimaps Group Developer of AI-powered bone health assessment software | $20M | 56 mo ago | Series B | Didier Hans CEO & President | 2006 | WordPressMySQLPHP+15 | 33 patents AI-driven texture analysis of medical imaging for tissue and bone diagnostics | — |
| 4 | SYRHA Tech Providing management consulting services to medical device manufacturers | $5M | 14 mo ago | Series A | Gilles Bos Founder | 2018 | WordPressMySQLPHP+16 | — | — |
| 5 | AERA Health Provider of testing, team training, support, and coaching services | $4M | 40 mo ago | Seed | Andrea Gartenbach Co-Founder | 2022 | — | — | — |
| 6 | FluoSphera CRO focused on providing drug development services for biopharma sector | $2M | 6 mo ago | Seed | Aurélien Roux Co-Founder | 2020 | — | — | 1 partnership |
| 7 | HMCARE Manufacturer of face masks | $1M | 73 mo ago | Seed | Diane Baatard Co-Founder | 2020 | — | — | — |
| 8 | Epithelix Provider of 3D tissue and testing services for in-vitro drug testing for respiratory cells | $611K | 79 mo ago | Seed | Samuel Constant COO & Co-Founder | 2006 | PHPGoogle MapsVimeo+11 | — | — |
| 9 | Food for Health Provider of organic superfoods for a higher quality life | $124K | 38 mo ago | Seed | Sergio Panzarella Founder & CEO | 2019 | Cart FunctionalityShopifyShop Pay+26 | — | — |
| 10 | HeroSupport Provider of personalise medical treatment services for patients comforts | $114K | 29 mo ago | Seed | Giovanna Dipasquale Chief Executive Officer | 2019 | — | — | — |
Top 12 Healthcare companies in Geneva
#1
Seed · Geneva, Geneva · founded 2020 · 3 employees$2Mraised▾
CRO focused on providing drug development services for biopharma sector
- Jan 2026Seed$1.4M
- Mar 2023Seed$1M
- Dec 2022Seed$1M
- Aug 2021Grant (prize money)$54.6K
#2
Series A · Plan les Ouates, Geneva · founded 2018 · 10 employees$5.5Mraised▾
Developer of injectable medical devices designed for medical applications. The company makes visco-elastic alternatives for aesthetic dermatology, orthopedics, and ophthalmology and offers CDMO (contract development and manufacturing organization) activities with a high level of performance, quality, and competence. enabling clients to formulate their customized products using technological and scientific formulation assistance.
- May 2025Series A$5.5M
#3
Acquired · Geneva, Geneva · founded 2017 · 70 employees$43.3Mraised▾
Develops and manufactures a range of medical devices for hand and wrist surgery
- Mar 2023Series C$32.3M
- Nov 2020Series B$11M
#4
Acquired · Geneva, Geneva · founded 2006 · 11 employees$51.8Mraised▾
Genkyotex develops small molecule therapeutics that selectively inhibit the NOX family of enzymes. This technology is targeted towards the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases. The company’s lead product is GKT831, a dual inhibitor of NOX4 and NOX1, which is in clinical development for the treatment of scleroderma (chronic connective tissue) and NASH (liver disease).
- Aug 2018Post IPO$5.6M
- Jan 2015Post IPO$21M
- Jul 2012Series C$26M
- May 2011Series C$20.4M
#5
Series B · Geneva, Geneva · founded 2006$20Mraised▾
Developer of AI-powered bone health assessment software. This software comprehensively assesses bone microarchitecture and predicts fracture risk using existing imaging data. The technology integrates into clinical workflows, providing clinicians with tools to improve fracture risk detection, treatment planning, and monitoring. It offers insights beyond bone density, considering bone microarchitecture for a more complete patient assessment. The software is designed for ease of use and efficiency within clinical settings.
- Dec 2021Series B$20M
#6
Seed · Geneva, Geneva · founded 2022$4.3Mraised▾
Provider of testing, team training, support, and coaching services
- Mar 2023Seed$4.3M
#7
Seed · Veyrier, Geneva · founded 2019 · 4 employees$113.7Kraised▾
Manufacturer of medical immobilization devices intended to offer patient comfort in clinical practice. The company's device transforms imaging and treatment tables into personalized support so that patients do not have to adjust to the table for prone breast radiotherapy, enabling doctors to improve cancer treatment effectively and cost efficiency.
- Feb 2024Seed$113.7K
- Aug 2021Grant (prize money)$54.6K
#8
Seed · Geneva, Geneva · founded 2020 · 4 employees$1Mraised▾
Manufacturer of face masks
- Jun 2020Seed$1M
#9
Seed · Geneva, Geneva · founded 2019 · 2 employees$123.6Kraised▾
Food For Health is a company that focuses on providing organic superfoods for a higher quality life. They research, grow, and select natural products to create their products, which combine science and nature. They offer a fruit juice called Ólixir and prioritize social health over shareholder wealth.
- May 2023Seed$123.6K
#10
Seed · Plan les Ouates, Geneva · founded 2006$611.5Kraised▾
Epithelix is a tissue engineering company providing in-vitro solutions for drug development and toxicity testing for the human respiratory tract. Epithelix provides R&D solutions to Pharma/Biotechs for the study of human respiratory diseases (asthma, COPD, cystic fibrosis, etc.) in order to reduce animal experiments. Its main product, MucilAir, is a 3-D model of the human airway epithelium made up of primary human cells isolated from the nasal cavity, trachea, and bronchus.
- Jan 2020Grant (prize money)$556.5K
- Jun 2007Grant (prize money)$55K
- Seed—
#11
Deadpooled · Plan les Ouates, Geneva · founded 2014$37.5Kraised▾
Oncotheis is a Swiss tissue engineering start-up providing in-vitro solutions (bioengineered tissues and organoids) for drug development and toxicity testing for cancer research. It provides integrated 3D in vitro models with both healthy and cancerous tissues for simulating the in vivo situation. Their primary product is a lung-cancer model based exclusively on human cells, OncoCilAir, that mimics in vitro the progression of the disease. Since it includes both healthy and cancerous tissues, OncoCilAir can be used to test tumor-killing action as well as adverse effects of chemotherapy and other anticancer drugs.
- Nov 2015Grant (prize money)$37.5K
- 2014Seed—
#12
Seed · Geneva, Geneva · founded 2016$10Kraised▾
MesenFlow Technologies provides a high-throughput system that measures inflammatory responses in proprietary human tissue engineering system that mimics physiological inflammation. It uses a bio-imaging technique to measure recruitment & retention of leukocytes non-invasively. The company has recently extended this technology for use in cosmetics and nutrition. The company claims that its technology will help in reducing animal testing in preclinical development.
- May 2017Seed$10K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.